Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Theodora Hatziioannou
Affiliation
The Rockefeller University
ORCID
Career Start Year
1995
Papers
127
H Index
53
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36473496
Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination.
Nature
2023
37625266
Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIV.
EBioMedicine
2023
38096415
Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies.
Proc Natl Acad Sci U S A
2023
37563124
SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates.
Nat Commun
2023
36952347
Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain.
Cell Rep
2023
37425700
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity.
bioRxiv
2023
37188812
Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies.
Nat Microbiol
2023
37368240
Memory B cell development elicited by mRNA booster vaccinations in the elderly.
J Exp Med
2023
36653360
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape.
Nat Commun
2023
35194607
Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose.
bioRxiv
2022
35776090
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans.
J Exp Med
2022
35735743
Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population.
mBio
2022
35796685
Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants.
J Exp Med
2022
35636436
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis.
Lancet Microbe
2022
35818364
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection.
Open Forum Infect Dis
2022
35358263
Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting.
PLoS One
2022
35447092
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins.
Immunity
2022
35447027
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost.
Nature
2022
36149398
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans.
J Exp Med
2022
35982682
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination.
medRxiv
2022
36052368
Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain.
bioRxiv
2022
36006380
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens.
J Exp Med
2022
35132412
Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins.
bioRxiv
2022
35030645
Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
N Engl J Med
2022
35169812
Antibody and memory B-cell immunity in a heterogeneously SARS-CoV-2 infected and vaccinated population.
medRxiv
2022
33173867
Evolution of Antibody Immunity to SARS-CoV-2.
bioRxiv
2021
33882219
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
N Engl J Med
2021
33767445
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.
Nature
2021
33851164
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.
bioRxiv
2021
33567448
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Nature
2021
33758864
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies.
bioRxiv
2021
33758856
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies.
bioRxiv
2021
33501451
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
bioRxiv
2021
33501434
Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease.
bioRxiv
2021
33688659
Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants.
bioRxiv
2021
34936878
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Cell Rep
2021
34874007
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.
Elife
2021
34931199
Plasma neutralization properties of the SARS-CoV-2 Omicron variant.
medRxiv
2021
35262014
Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland.
J Clin Virol Plus
2021
34648371
Replication and single-cycle delivery of SARS-CoV-2 replicons.
Science
2021
34544114
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.
Nature
2021
34716452
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol
2021
34534459
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
Cell Rep
2021
34619745
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination.
Nature
2021
34126625
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.
Nature
2021
34100013
Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year.
bioRxiv
2021
34098567
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.
Nature
2021
34345019
Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.
Nature
2021
34268524
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity.
medRxiv
2021
34234131
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.
Nat Commun
2021
1 - 50 of 127
Column Actions
Search
Recommended Authors
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
4
Craig B Wilen
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
3
Blandine Monel
Institut Pasteur, CNRS UMR 3569
Career Start Year
2009
Number of shared co-authors
1
Suzannah J Rihn
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year
2008
Number of shared co-authors
6
Kei Sato
The Institute of Medical Science, The University of Tokyo
Career Start Year
2008
Number of shared co-authors
0
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year
2008
Number of shared co-authors
1
Jason A Wojcechowskyj
Gladstone Institutes
Career Start Year
2007
Number of shared co-authors
0
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year
2005
Number of shared co-authors
2
Lingshu Wang
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year
2003
Number of shared co-authors
6
Felipe Diaz-Griffero
Albert Einstein College of Medicine
Career Start Year
2002
Number of shared co-authors
1
Samir K Lakhashe
Texas Biomedical Research Institute
Career Start Year
2002
Number of shared co-authors
2
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year
1997
Number of shared co-authors
10
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year
1995
Number of shared co-authors
6
Cynthia A Derdeyn
University of Washington
Career Start Year
1995
Number of shared co-authors
4
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
3
Vicente Planelles
University of Utah
Career Start Year
1991
Number of shared co-authors
1
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year
1988
Number of shared co-authors
0
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year
1987
Number of shared co-authors
4
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
1
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year
1985
Number of shared co-authors
1
Michael S Diamond
Washington University School of Medicine
Career Start Year
1982
Number of shared co-authors
7
Michael Emerman
Fred Hutchinson Cancer Center
Career Start Year
1982
Number of shared co-authors
5
Timothy R Fouts
Profectus BioSciences Inc.
Career Start Year
1981
Number of shared co-authors
0
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year
1979
Number of shared co-authors
2
John Guatelli
University of California San Diego, USA VA San Diego Healthcare System
Career Start Year
1978
Number of shared co-authors
1
James E Crowe
Vanderbilt University Medical Center
Career Start Year
1975
Number of shared co-authors
4
Robert F Garry
Tulane University School of Medicine
Career Start Year
1974
Number of shared co-authors
1
Ronald Swanstrom
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year
1972
Number of shared co-authors
7
Eric Hunter
Center for Family Health Research Zambia
Career Start Year
1971
Number of shared co-authors
4
Ruth M Ruprecht
University of Texas San Antonio
Career Start Year
1971
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Paul D Bieniasz
The Rockefeller University
Co-authored papers
113
Fabian Schmidt
The Rockefeller University
Co-authored papers
52
Yiska Weisblum
Rockefeller University
Co-authored papers
27
Thiago Y Oliveira
The Rockefeller University
Co-authored papers
22
Pamela J Bjorkman
Co-authored papers
18
Charles M Rice
Rockefeller University
Co-authored papers
16
Hans-Heinrich Hoffmann
The Rockefeller University
Co-authored papers
12
Jeffrey D Lifson
Frederick National Laboratory
Co-authored papers
10
Brandon F Keele
Co-authored papers
7
Stephen P Goff
Columbia University
Co-authored papers
6
George M Shaw
Co-authored papers
5
Beatrice H Hahn
Co-authored papers
5
Peter D Kwong
Co-authored papers
5
Jacob D Estes
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers
5
Michael P Rout
The Rockefeller University
Co-authored papers
3
Gwo-Yu Chuang
Co-authored papers
3
Jan Rozman
German Center for Diabetes Research (DZD)
Co-authored papers
3
David C Montefiori
Co-authored papers
3
Thomas J Ketas
Co-authored papers
3
Tongqing Zhou
Co-authored papers
3
Frederic Bibollet-Ruche
Co-authored papers
3
David Noah Sather
Center for Global Infectious Disease Research, Seattle Children's Hospital
Co-authored papers
2
Robert A Colbert
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers
2
Kai Xu
Co-authored papers
2
Junjie Wang
The Rockefeller University
Co-authored papers
2
Fred D Mast
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Co-authored papers
2
Natalia E Ketaren
The Rockefeller University
Co-authored papers
2
Zandrea Ambrose
Co-authored papers
2
Celia C LaBranche
Co-authored papers
2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers
2
1 - 30